Many cardiologists monitor pacemakers and other cardiovascular implantable electronic devices (CIEDs) remotely. Forward-thinking practices are now integrating their monitoring software into their electronic medical records system (EMR)
Case Study: Using Strain Echo to Recognize Cardiotoxicity from Cancer Therapy
Strain echocardiography allows detection of small changes in ventricular function, enabling early cardioprotection for cancer patients whose chemotherapy puts them at risk for heart failure.
Going Bioabsorbable with Next-Generation Vascular Scaffolding
The ABSORB trial is assessing a new bioabsorbable device designed to match the performance of metallic drug-eluting stents before it dissolves to avoid long-term thrombotic risk.
Tiny Nanoparticles May Make Huge Impact in Cancer Medicine
Submicroscopic nanoparticles may help overcome the obstacles that hamper traditional anti-cancer drugs. Their size and other unique properties enable targeted drug delivery to hard-to-access tumors, as well as aiding tumor boundary visualization.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Responsiveness Project: Tapping Teamwork and Accountability to Improve Patient Experience
Providing world-class cancer care can be demanding. With more than 46,000 inpatients treated at Cleveland Clinic’s Taussig Cancer Institute in 2010 alone, Cancer Institute nurses understand this all too well.
Mind Over Matter in Heart Care
Mental health is increasingly recognized as important to heart health. Here are lessons from Cleveland Clinic’s introduction of mental health services into a cardiology clinic.
Scoring Success in Supply Chain Management
Cleveland Clinic’s move toward value-based purchasing saved more than $150 million over two years, with a third of the savings in cardiovascular care. Cardiovascular leaders share insights gained.
Telemedicine Program Broadens Access to Radiation Oncology in Africa
International effort allows experts to confer on complex cases
Research Shows HDL Has Cancer-Fighting Ability
Apolipoprotein A1, a major component of HDL, blocks metastatic malignant melanoma and lung cancer through multiple pathways. ApoA1 injections not only inhibit tumor growth and progression in mice, but spur tumor and metastases regression.
Going Green in the Lab Saves Money
Recycling isn’t just good for the earth—it can benefit a hospital’s bottom line, too.